Orion Oyj Logo

Orion Oyj

ORNAV | HE

Overview

Corporate Details

ISIN(s):
FI0009014377 (+1 more)
LEI:
74370029VAHCXDR7B745
Country:
Finland
Address:
Orionintie 1, FI-02200 ESPOO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are oncology and pain. Orion's customers are mainly healthcare service providers and professionals such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centres, clinics and laboratories. Consumers with pets are another important customer group. Orion's main market is Finland, where it is the clear market leader. Orion’s products are marketed in over a hundred countries, and the Group's own human pharmaceuticals sales organisation covers almost all key European markets and a few Southeast Asian countries. In other markets Orion’s products are sold by several collaboration partners.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-08 08:30
Director's Dealing
Orion Oyj: Johtohenkilöiden liiketoimet - Juhani Kankaanpää
Finnish 4.9 KB
2025-08-08 08:30
Director's Dealing
Orion Corporation: Managers' transactions - Juhani Kankaanpää
English 4.8 KB
2025-08-04 15:10
Director's Dealing
Orion Oyj: Johtohenkilöiden liiketoimet - Satu Ahomäki
Finnish 3.5 KB
2025-08-04 15:10
Director's Dealing
Orion Corporation: Managers' transactions - Satu Ahomäki
English 3.5 KB
2025-07-18 11:00
Interim Report
Orion-konsernin puolivuosikatsaus tammi-kesäkuu 2025
Finnish 18.4 KB
2025-07-18 11:00
Earnings Release
Orion Group Half-Year Financial Report January-June 2025
English 18.3 KB
2025-07-18 08:30
Report Publication Announcement
Orion-konsernin tulosjulkistukset ja yhtiökokous vuonna 2026
Finnish 3.4 KB
2025-07-18 08:30
Report Publication Announcement
Orion Corporation's financial reporting and Annual General Meeting in 2026
English 3.6 KB
2025-07-09 12:00
Management Discussion and Analysis
Sisäpiiritieto: Orion parantaa näkymäarviota vuodelle 2025
Finnish 3.5 KB
2025-07-09 12:00
Earnings Release
Inside information: Orion upgrades full-year outlook for 2025
English 3.6 KB
2025-06-23 08:30
Declaration of Voting Results & Voting Rights Announcements
141 959 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish 2.7 KB
2025-06-23 08:30
Declaration of Voting Results & Voting Rights Announcements
141,959 Orion Corporation A shares converted into B shares
English 2.8 KB
2025-05-08 14:30
Major Shareholding Notification
Orion Corporation: Disclosure Under..
Finnish 5.6 KB
2025-05-08 14:30
Major Shareholding Notification
Orion Corporation: Disclosure Under..
English 5.7 KB
2025-05-07 15:00
Major Shareholding Notification
Orion Corporation: Disclosure Under..
Finnish 5.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo ABIVAX France ABVX
Addex Therapeutics Ltd Logo Addex Therapeutics Ltd Switzerland ADXN
AegirBio AB Logo AegirBio AB Sweden AEGIR
AGRONOMICS LIMITED Logo AGRONOMICS LIMITED Isle of Man ANIC
AIREA PLC Logo AIREA PLC United Kingdom AIEA
Alkaloid AD Logo Alkaloid AD North Macedonia ALK
Alma Yesodot Ltd. Israel KVSR
Amphastar Pharmaceuticals Inc. Logo Amphastar Pharmaceuticals Inc. United States of America AMPH
Ananda Pharma Plc United Kingdom N/A
AnGes, Inc. Logo AnGes, Inc. Japan 4563